$7.39
-0.26-3.40%
At close: -
$7.99
0.608.12%
After Hours: Jan 13, 4:00 AM EDT
Addex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Addex Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2021-11-04 | $-14.40 | $-14.40 | 0.00 % |
Q2 | 2021-08-05 | $-18.00 | $-13.00 | -38.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2024-09-30 | $127.15K | $ | -51.1 % |
Q3 | 2023-11-29 | $370.87K | $700.00K | -47.0 % |
Q3 | 2021-11-04 | $825.37K | $420.00K | 96.5 % |
Q2 | 2021-08-05 | $1.18M | $260.00K | 452307600.0 % |
Addex Therapeutics (ADXN) is scheduled to report earnings on March 24, 2025. The last reported earnings were for reported on November 22, 2024 for Q3.
The Actual EPS was $-2.77, which missed the estimate of $0.00.
The Actual Revenue was $68.2K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.